|
|
|
Breast Cancer Health Faculty |
|
|
|
|
Lodovico Balducci, MD
|
Paul Goss, MD, PhD, FRCPC, FRCP
|
|
|
Stephen E. Jones, MD
|
Terry P. Mamounas, MD
|
|
|
Joanne E. Mortimer, MD
|
Hyman B. Muss, MD
|
|
|
Joyce O'Shaughnessy, MD
|
Kathleen Pritchard, MD
|
|
|
Hope S. Rugo, MD
|
|
|
|
|
|
Lodovico Balducci, MD
Lodovico Balducci, MD, is professor of Medicine and attending physician at the University of South Florida College of Medicine in Tampa, Florida. He is also program leader of the Senior Adult Oncology Program at the H. Lee Moffitt Cancer Center and Research Institute in Tampa.
Active in the American Society of Clinical Oncology (ASCO), Dr Balducci serves on the Task Force on Aging. He is a member of the American Federation for Clinical Research, the American Society of Breast Disease, and the International Society for Experimental Hematology, among others. Dr Balducci participates in the Eastern Cooperative Oncology Group, is a member of the Group's Breast Committee, and currently chairs the Subcommittee on Aging.
Dr Balducci serves on the editorial boards of the Journal of Experimental and Clinical Cancer Research, the Journal of the American Geriatrics Society, and Cancer Control: The Journal of the Moffitt Cancer Center; he is a reviewer for Annals of Internal Medicine and the American Journal of Hematology, among others. He acted as senior-editor of Comprehensive Geriatric Oncology (Harwood Academic Publishers, 1998). Recent and upcoming publications include chapters on cancer and aging in Principles and Practice of Geriatric Surgery (Springer Verlag) and Cancer Treatment (WB Saunders Co) and a review of management of cancer in the elderly in Clinical Geriatrics. Dr Balducci's research interests include assessment and treatment of the older person with cancer.
Dr Balducci earned his medical degree at Catholic University in Rome, Italy, and completed a fellowship in medicine at Gemelli General Hospital. After finishing a rotating internship at Misericordia General in Manitoba, Canada, he completed an internship and residency in medicine, followed by a fellowship in hematology/oncology, at the University of Mississippi Medical Center in Jackson. He is a fellow of the American College of Physicians.
Back to top >>
|
|
|
Paul Goss, MD, PhD, FRCPC, FRCP
University of Toronto, Canada
Back to top >>
|
|
|
Stephen E. Jones, MD
Baylor-Sammons Cancer Center, Dallas, Texas
Back to top >>
|
|
|
Terry P. Mamounas, MD
Aultman Hospital, Canton, Ohio
Back to top >>
|
|
|
Joanne E. Mortimer, MD
Washington University, St. Louis, Missouri
Back to top >>
|
|
|
Hyman B. Muss, MD
University of Vermont College of Medicine
Back to top >>
|
|
|
Joyce O'Shaughnessy, MD
Joyce Ann O'Shaughnessy, M.D. graduated summa cum laude from Holy Cross College in 1978 and served on the Holy Cross College Board of Trustees from 1988 to 1996. She graduated cum laude from Yale University Medical School in 1982. Dr. O'Shaughnessy did her internship and residence in Internal Medicine at Massachusetts General Hospital followed by her fellowship in Medical Oncology at the National Cancer Institute. Dr. O'Shaughnessy served as Special Assistant to the National Cancer Institute director from 1988 to 1990 and coordinated the development of new cancer drug approval guidelines for the National Cancer Institute and Food and Drug Administration. Dr. O'Shaughnessy then served as a Senior Investigator in the Medical Breast Cancer Section of the National Cancer Institute from 1990 through 1995. In this role she conducted many breast cancer treatment clinical trials including evaluation of high-dose chemotherapies and hematopoietic growth factors, new cytotoxic drug combinations, novel hormonal treatments, monoclonal antibody and gene therapies for breast cancer. Dr. O'Shaughnessy has also served as principal investigator on several tissue-based breast cancer prevention clinical trials involving the administration of fenretinide, tamoxifen, and other SERM's to women at high risk for the development of breast cancer. Dr. O'Shaughnessy has published and spoken widely on new prevention and treatment strategies for breast cancer.
Dr. O'Shaughnessy is presently a breast cancer researcher and practitioner in Texas Oncology, P.A. Dr. O'Shaughnessy is Associate Director for clinical research for US Oncology and is Director, Chemoprevention Research and Co-Director, Breast Cancer Research for US Oncology. Dr. O'Shaughnessy's major area of research interest is the development of new chemoprevention strategies for women at high risk for the development of breast cancer and she is involved in several ongoing chemoprevention studies.
Back to top >>
|
|
|
Kathleen Pritchard, MD
Dr. Pritchard is currently Chair of the Breast Cancer Site Group at the Toronto-Sunnybrook Regional Cancer Center and Sunnybrook and Women's College Health Sciences Center. She is head of the Division of Clinical Trials and Epidemiology, Clinical Director of the Ontario Clinical Oncology Group, Co-Chair of the Breast Cancer Site Group of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) and Professor of Medicine at the University of Toronto.
Dr. Pritchard's research interests include: multicenter clinical trials (design, conduct and analysis), adjuvant therapy for breast cancer, correlative and translational research in breast cancer, tumor/tissue/serum/data banking, predictive and prognostic factors in breast cancer, hormonal therapy for breast cancer and menopausal symptoms and their effect on quality of life in women with a diagnosis of breast cancer.
Kathleen Pritchard is one of Sunnybrook's best-known academic physicians. Apart from her ongoing clinical and administrative duties as a member of the Division of Medical Oncology/Haematology and Head of Clinical Trials & Epidemiology at the Toronto-Sunnybrook Regional Cancer Centre, she has maintained a productive program of research in the field of breast cancer. Dr. Pritchard holds a major leadership role in a number of national and international multicentre clinical trials, and is widely published in the major general medical and cancer journals. Dr. Pritchard is a frequent consultant for or member of independent data and safety monitoring committees for clinical trials world-wide.
Back to top >>
|
|
|
Hope S. Rugo, MD
Dr. Hope Rugo is a medical oncologist and hematologist specializing in breast cancer research and treatment. An associate clinical professor of medicine at the University of California San Francisco Comprehensive Cancer Center, Dr. Rugo treats patients and participates in clinical research at the Breast Care Center. She has worked in the past in the field of malignant hematology and bone marrow transplantation for a variety of diseases, including breast cancer.
Dr. Rugo entered the field of breast cancer in order to incorporate novel therapies based on an understanding of the biology of cancer with excellent quality of care into the treatment of women with breast cancer.
Dr. Rugo is the principal investigator of several clinical trials focusing on using novel agents, combinations of agents, or vaccines to treat advanced breast cancer. She is actively participating in numerous other clinical trials assessing the effects of new hormonal and chemotherapeutic agents as well as combination herbal therapy. She is an investigator of SPORE (the Bay Area Specialized Program of Research Excellence in Breast Cancer). Dr. Rugo teaches medical students and physicians, and regularly lectures in the community on the treatment of breast cancer.
Dr. Rugo graduated from the University of Pennsylvania School of Medicine in 1983. She completed a residency in internal medicine and primary care followed by a fellowship in hematology and oncology at the University of California San Francisco. She was a post-doctoral fellow in immunology participating in laboratory research at Stanford University from 1988-1990. In 1990, Dr. Rugo joined the faculty at UCSF in the Division of Hematology and Oncology.
Back to top >>
|
|
|
|
|
|
